About CoAptus Medical
CoAptus Medical was a Healthcare company based in Redmond (United States) founded in 2003 by Joseph E. Eichinger. It develops non-implant therapeutics for treating patent foramen ovale, a structural heart defect. It operates on a B2B model. CoAptus Medical has raised $3 million across 1 funding round. The company has 40 employees. Its website coaptus.com draws about 681 thousand monthly visits. The company is recorded as dissolved. Its focus areas include Medical Devices, Cardiovascular and Non-Implant Therapeutics. Its legal entity is CYBERSAINT, INC. Its competitors include Xeltis, PECA Labs, Occlutech, Endonovo Therapeutics and Coherex and 3 more; 5 of its 8 listed competitors have raised funding.
Company details
CoAptus Medical operates with a B2B model, focusing on providing healthcare solutions, developing medical devices, cardiovascular, and non-implant therapeutics. Develops non-implant therapeutics for treating patent foramen ovale, a structural heart defect. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Redmond, United States
- Employees 40
- Founders Joseph E. Eichinger
- SectorsHealthcare
- Website coaptus.com
- Legal Name Cybersaint, Inc.
- Total Equity Funding$3M (USD)
in 1 rounds
- Latest Funding Round$3M (USD), Series A
May 2009
- Employee Count40
Funding Insights of CoAptus Medical
CoAptus Medical has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Series A round of $3 million completed in May 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3M
- Total Rounds 1
- Last Round Series A — $3M
- First Round $3M
(May 2009)
All 1 funding rounds of CoAptus Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2009 | $3M | Series A | – | – | – |
People of CoAptus Medical
1 people are tracked at CoAptus Medical (1 in leadership); the tracked headcount is 40.
| Name | Role | Group |
|---|---|---|
Joseph E. Eichinger | Co-Founder | Leadership |
Complete people profiles for CoAptus Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CoAptus Medical
2 dated milestones of CoAptus Medical across 6 years, from founding to its latest funding, stage changes and deals.
- Founded CoAptus Medical is founded.
- Funding First funding round of $3.0M.
Competitors of CoAptus Medical
CoAptus Medical has 8 listed competitors in our database, 5 of them funded. They include Xeltis, PECA Labs, Occlutech, Endonovo Therapeutics and Coherex, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| xeltis.com | 2006 | Zurich, Switzerland | $164.42M | – | Developer of bioabsorbable synthetic heart valves and vascular grafts | |
| pecalabs.com | 2011 | Pittsburgh, United States | $19.91M | – | Pediatric cardiac surgical devices are developed for congenital heart defects. | |
| occlutech.com | 2003 | Schaffhausen, Switzerland | $70.81M | – | Provider of minimally invasive cardiac devices for congenital heart defects, stroke prevention and heart failure | |
| endonovo.com | 2011 | Los Angeles, United States | – | – | Bioelectronic devices are developed for regenerative medicine therapies. | |
| coherex.com | 2003 | Salt Lake, United States | $25.03M | 19 | Structural heart disease conditions are addressed with implant devices. | |
| cardia.com | 1998 | Eagan, United States | – | – | Products for transvenous closures of certain types of congenital heart defects. | |
| amplatzer.com | 1995 | Plymouth, United States | – | – | Devices to treat congenital heart diseases and peripheral vascular diseases | |
| elevatedcpr.com | 2015 | Edina, United States | $9.51M | – | CPR products for sudden cardiac arrest treatment are developed. |
Detailed competitors of CoAptus Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CoAptus Medical
The website of CoAptus Medical (coaptus.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with CoAptus Medical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for CoAptus Medical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as CoAptus Medical (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CoAptus Medical
CoAptus Medical was founded in 2003 and raised its 1st funding round 6 years after it was founded.
CoAptus Medical is headquartered in Redmond, United States. It is registered at Redmond, Washington, United States.
CoAptus Medical is a funded company, having raised a total of $3M across 1 funding round to date. The company's 1st funding round was a Series A of $3M, raised on May 2009.
CoAptus Medical has 40 employees.
CoAptus Medical operates with a B2B model, focusing on providing healthcare solutions, developing medical devices, cardiovascular, and non-implant therapeutics. Develops non-implant therapeutics for treating patent foramen ovale, a structural heart defect. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
CoAptus Medical's top competitors include Xeltis, PECA Labs and Endonovo Therapeutics.
CoAptus Medical operates through Cybersaint, Inc..
The website of CoAptus Medical receives about 681 thousand visits a month.